NT$30.80
+
NT$2.40 (8.45%)
End-of-day quote: 02/26/2024
TPEX:6461
Intech Biopharm Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| AZN | AstraZeneca PLC | LSE | Outperform | £121.10 | £165.99 | 0.00% | 16 | £187.73B |
| GSK | GSK | LSE | Outperform | £17.75 | £17.30 | 0.00% | 12 | £72.39B |
| MMM | 3M | NYSE | Hold | $105.26 | $109.39 | 0.00% | 3 | $58.25B |
| TEVA | Teva Pharmaceutical Industries | NYSE | Outperform | $16.29 | $11.59 | 0.00% | 9 | $18.45B |
